Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL48452Aexternal-prioritypatent/IL48452A/xx
Application filed by Mundipharma AgfiledCriticalMundipharma Ag
Priority claimed from US05/751,851external-prioritypatent/US4105776A/en
Publication of SE7612526LpublicationCriticalpatent/SE7612526L/sv
Publication of SE426700BpublicationCriticalpatent/SE426700B/sv
C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
C07D491/20—Spiro-condensed systems
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
SE7612526A1975-11-111976-11-10Analogiforfarande for framstellning av spiro-(1,3-dioxolan-4,3')-kinuklidiner med terapeutisk verkan
SE426700B
(sv)